Biotech · Private company
K36 Therapeutics, Inc.
Track this companyFree. Adds K36 Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Cohort A1 & A2: KTX-1001Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Cohort B1 & B2: KTX-1001+MezigdomidePhase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Cohort C1 & C2: KTX-1001 + Carfilzomib (KYPROLIS®)Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Cohort D: KTX-1001+ pomalidomide (Pomalyst, Imnovid)Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- KTX-2001Phase 1 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- KTX-2001 + Darolutamide (NUBEQA®)Phase 1 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)PHASE1 · RECRUITING · started Nov 21, 2025ClinicalTrials.gov NCT07103018 · fetched Nov 12, 2026
- A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaPHASE1 · RECRUITING · started Feb 22, 2023ClinicalTrials.gov NCT05651932 · fetched Nov 12, 2026